Sebastian Polak

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 17

Top Venues

International journal of molecular sciences

Pharmaceutics

Computational and mathematical methods in medicine

Clinical pharmacology and therapeutics

Uniwersytet Jagiellonski w Krakowie Collegium Medicum

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Uniwersytet Jagiellonski w Krakowie Collegium Medicum Jun 01 1999

Poland

Associate Professor :: Fafulty of Pharmacy

Publications

Olha Shuklinova, Gabriela Wyszogrodzka-Gaweł, Ewelina Baran, Bartosz Lisowski, Barbara Wiśniowska, Przemysław Dorożyński, Piotr Kulinowski, Sebastian Polak
Can 3D Printed Tablets Be Bioequivalent and How to Test It: A PBPK Model Based Virtual Bioequivalence Study for Ropinirole Modified Release Tablets. Pharmaceutics 16 (2) (2024)
Olha Shuklinova, Sibylle Neuhoff, Sebastian Polak
How PBPK Can Help to Understand Old Drugs and Inform their Dosing in Elderly: Amantadine Case Study. Clinical pharmacology and therapeutics 116 (1) (2024)
Olha Shuklinova, Gabriela Wyszogrodzka-Gaweł, Ewelina Baran, Bartosz Lisowski, Barbara Wiśniowska, Przemysław Dorożyński, Piotr Kulinowski, Sebastian Polak
Can 3D Printed Tablets Be Bioequivalent and How to Test It: A PBPK Model Based Virtual Bioequivalence Study for Ropinirole Modified Release Tablets. Pharmaceutics 16 (2) (2024)
Olha Shuklinova, Sibylle Neuhoff, Sebastian Polak
How PBPK Can Help to Understand Old Drugs and Inform their Dosing in Elderly: Amantadine Case Study. Clinical pharmacology and therapeutics (2024)
Jakub Witkowski, Sebastian Polak, Dariusz Pawelec, Zbigniew Rogulski
In Vitro/In Vivo Translation of Synergistic Combination of MDM2 and MEK Inhibitors in Melanoma Using PBPK/PD Modelling: Part III. International journal of molecular sciences 24 (3) (2023)
Jakub Witkowski, Sebastian Polak, Dariusz Pawelec, Zbigniew Rogulski
In Vitro/In Vivo Translation of Synergistic Combination of MDM2 and MEK Inhibitors in Melanoma Using PBPK/PD Modelling: Part III. International journal of molecular sciences 24 (3) (2023)
Marcela Wiater, Michał Romański, Sebastian Polak, Grzegorz Garbacz, Justyna Dobosz, Daria Myslitska, Svitlana Romanova, Jadwiga Paszkowska, Dorota Danielak
A Rational Approach to Predicting Immediate Release Formulation Behavior in Multiple Gastric Motility Patterns: A Combination of a Biorelevant Apparatus, Design of Experiments, and Machine Learning. Pharmaceutics 15 (8) (2023)
Jadwiga Kalicińska, Barbara Wiśniowska, Sebastian Polak, Radoslaw Spiewak
Artificial Intelligence That Predicts Sensitizing Potential of Cosmetic Ingredients with Accuracy Comparable to Animal and In Vitro Tests-How Does the Infotechnomics Compare to Other "Omics" in the Cosmetics Safety Assessment? International journal of molecular sciences 24 (7) (2023)
Jakub Witkowski, Sebastian Polak, Dariusz Pawelec, Zbigniew Rogulski
In Vitro/In Vivo Translation of Synergistic Combination of MDM2 and MEK Inhibitors in Melanoma Using PBPK/PD Modelling: Part III. International journal of molecular sciences 24 (3) (2023)
Jakub Witkowski, Sebastian Polak, Dariusz Pawelec, Zbigniew Rogulski
In Vitro/In Vivo Translation of Synergistic Combination of MDM2 and MEK Inhibitors in Melanoma Using PBPK/PD Modelling: Part III. International journal of molecular sciences 24 (3) (2023)
Olha Shuklinova, Przemysław Dorożyński, Piotr Kulinowski, Sebastian Polak
Quality Control Dissolution Data Is Biopredictive for a Modified Release Ropinirole Formulation: Virtual Experiment with the Use of Re-Developed and Verified PBPK Model. Pharmaceutics 14 (7) (2022)
Barbara Wiśniowska, Joanna Giebułtowicz, Roman Piotrowski, Piotr Kułakowski, Sebastian Polak
Development and Performance Verification of the PBPK Model for Antazoline and Its Metabolite and Its Utilization for Pharmacological Hypotheses Formulating. Pharmaceuticals (Basel, Switzerland) 15 (3) (2022)
Barbara Wiśniowska, Mark Holbrook, Christopher Pollard, Sebastian Polak
Utilization of mechanistic modelling and simulation to analyse fenspiride proarrhythmic potency - Role of physiological and other non-drug related parameters. Journal of clinical pharmacy and therapeutics (2022)
Barbara Wiśniowska, Zofia M Bielecka, Sebastian Polak
How circadian variability of the heart rate and plasma electrolytes concentration influence the cardiac electrophysiology - model-based case study. Journal of pharmacokinetics and pharmacodynamics 48 (3) (2021)
Joanna Giebułtowicz, Natalia Korytowska, Roman Piotrowski, Piotr Kułakowski, Gniewomir Latacz, Ewa Szymanska, Barbara Wiśniowska, Sebastian Polak
Characterization of In Vitro and In Vivo Metabolism of Antazoline Using Liquid Chromatography-Tandem Mass Spectrometry. International journal of molecular sciences 21 (24) (2020)
Sebastian Polak, Barbara Wiśniowska, Aleksander Mendyk, Adam Pacławski, Jakub Szlęk
Quantitative Assessment of the Physiological Parameters Influencing QT Interval Response to Medication: Application of Computational Intelligence Tools. Computational and mathematical methods in medicine 2018 (2018)
Barbara Wiśniowska, Bartosz Lisowski, Magdalena Kulig, Sebastian Polak
Drug interaction at hERG channel: In vitro assessment of the electrophysiological consequences of drug combinations and comparison against theoretical models. Journal of applied toxicology : JAT 38 (4) (2017)
Aleksander Mendyk, Sinan Güres, Renata Jachowicz, Jakub Szlęk, Sebastian Polak, Barbara Wiśniowska, Peter Kleinebudde
From Heuristic to Mathematical Modeling of Drugs Dissolution Profiles: Application of Artificial Neural Networks and Genetic Programming. Computational and mathematical methods in medicine 2015 (2015)

Sebastian Polak.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sebastian Polak